GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
New
Closed
Net new
Funds Holding
5,821
Funds Holding Change
+130
Funds Holding Growth
+2%
Value
$1.76T
Holding in Top 10
788
Top 10 Change
+41
Top 10 Growth
+5%
Value Growth
+18%
New
336
Increased
2,826
Reduced
2,243
Closed
135
Capital Inflow
$87.7B
Capital Outflow
$44.2B
Net Capital Flow
+$43.4B
Capital Flow Change
-$199B
Calls
$37.1B
Puts
$32B
Net Calls
+$5.09B
Put/Call Ratio
0.86